1-MCP treatments (mg·m−3) | Vase life (days) and relative increment (%) | AgNPs treatments (mg·dm−3) | Vase life (days) and relative increment (%) | SNP (mM) | Vase life (days) and relative increment (%) |
---|---|---|---|---|---|
Control | 6.5 ± 0.6d (100) | Control | 6.6 ± 0.9c (100) | Control | 6.8 ± 0.8d (100) |
100 | 9.4 ± 0.9c (145) | 50 | 9.0 ± 0.7b (135) | 0.1 | 9.3 ± 0.6c (136) |
200 | 13.1 ± 0.4a (203) | 100 | 12.1 ± 1.1a (182) | 0.2 | 12.1 ± 0.9b (177) |
300 | 11.9 ± 0.5b (184) | 150 | 11.5 ± 0.8a (173) | 0.3 | 15.9 ± 1.3a (233) |
0.4 | 14.2 ± 0.9a (208) |